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Factors produced by activated leukocytes alter renal epithelial leukin-8 (IL-8), adhesion molecules such as vascular cell
cell differentiation. The development of tubulointerstitial fi- adhesion molecule-1 (VCAM-1), and intercellular adhe-
brosis in inflammatory renal diseases has been linked to disease sion molecule-1 (ICAM-1), all of which serve to attractprogression to end-stage renal failure. Understanding the inter-
additional inflammatory cells to the interstitium [6]. Theactions of the factors influencing inflammation and activating
recruited mononuclear cells can then release an array ofthe fibrotic process, that is, the inflammatory infiltrate and the
resident proximal tubular cells, may lead to a determination inflammatory mediators that can injure tubular cells and
of the mechanisms that regulate tubulointerstitial fibrosis. We activate interstitial fibroblasts. The production of fibrotic
used an in vitro model of human proximal tubule cells that cytokines and the excessive synthesis of extracellularwere stimulated with supernatant from activated peripheral
matrix components by cells within the tubulointerstitiumblood mononuclear cells (leukocytes) to study the alterations
ensue, culminating in the development of tubulointersti-in cellular phenotype, and examined the signaling pathways
mediating epithelial-fibroblast like transdifferentiation. Our tial injury with subsequent fibrosis and disease progres-
hypothesis of the proposed sequence of events leading to tubu- sion [7]. In this study, human proximal tubular epithelial
lointerstitial fibrosis is explained. cells (HPTs) were stimulated with supernatant from acti-
vated peripheral mononuclear cells, and alterations in
cellular phenotype were assessed in an attempt to exam-
Tubulointerstitial fibrosis is the final common pathway ine the possible consequences of interactions between
for most inflammatory renal diseases that can progress to these major players in tubulointerstitial disease, namely,
end-stage renal failure, and the level of fibrosis correlates the inflammatory infiltrate and the resident proximal
closely with the loss of renal function observed in pa- tubular cells.
tients with chronic glomerular disease [1, 2]. The tubulo- Primary HPTs and the HK-2 proximal tubular cell
interstitial inflammatory infiltrate may play a major role line [8] were exposed to a supernatant from activated
in the pathogenesis of the tubular and interstitial lesions peripheral blood mononuclear cells (aPBMCs), and al-
observed in chronic glomerulonephritis. Many studies terations in the phenotype were assessed in terms of
have shown a strict correlation between tubular atrophy, morphology and marker protein expression. Alterations
interstitial fibrosis, and the extent of the interstitial infil- in transepithelial resistance were used as a measure of
trate [3, 4]. This infiltrate has been shown to consist of an the epithelial barrier function. Both HPT and HK-2 cells
inflammatory population of cells that is predominantly treated with the supernatant from activated mononu-
monocytes and T lymphocytes. It has been suggested that clear cells showed alterations in morphology to a more
these inflammatory cells are recruited into the inflamed elongated fibroblast-like cell type, as evidenced by phase
interstitium usually as a consequence of glomerular- contrast microscopy (Fig. 1) and supported by transmis-
derived inflammatory mediators that diffuse to the tu- sion electron microscopy. These alterations in cellular
bule stimulating its immune activation [5]. Following morphology were reversible upon removal of the immune
these glomerular-derived stimuli, tubular cells have been stimulus present in the supernatant from activated mo-
shown to express chemokines such as monocyte chemo- nonuclear cells. Treatment of HPT cells with aPBMCs
attractant protein-1 (MCP-1), RANTES, and inter- for 48 hours caused a significant decrease in transepithe-
lial resistance to 36 6 4% (P , 0.001) of control value
(abstract; Healy et al, Am Soc Nephrol 8:474A, 1997).Key words: tubulointerstitial disease, fibrosis, inflammation, proximal
tubule cells, end-stage renal failure. In addition, the expression of the epithelial junctional
proteins e-cadherin and occludin was down-regulated, 1999 by the International Society of Nephrology
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Fig. 1. Alterations in morphology induced by supernatant from acti-
vated peripheral blood mononuclear cells (PBMCs) in HK-2 cells. Hu-
man proximal tubule (HK-2) cells were exposed to 30% (vol/vol) super-
natant from activated PBMCs for 48 hours, and alterations in cellular
morphology were determined using phase contrast microscopy. At 48
hours, the cells were washed and given fresh medium for a further 24
hours. (A) HK-2 cells treated with vehicle alone. (B) HK-2 cells treated
with supernatant from activated PBMCs for 48 hours. (C) HK-2 cells
treated with PBMCs for 48 hours and allowed to recover for 24 hours.
and the mesenchymal marker vimentin was up-regulated experimental nephropathies, it has been hypothesized
that renal fibroblasts can be produced at sites of injuryin a time-dependent manner in treated cells. Preliminary
findings have also shown that parallel to these changes by conversion from tubular epithelial cells by this process
of transdifferentiation [10]. This hypothesis was verifiedin epithelial phenotype sustained activation of both the
p38 and p42/44 mitogen-activated protein (MAP) ki- in clinical studies whereby immunohistochemical analy-
sis of biopsy sections from patients with glomerulone-nases occurs. Therefore, some currently unknown factors
produced by the activated mononuclear cells are capable phritis demonstrated that some tubular epithelial cells
were being altered to collagen-producing fibroblast cellsof inducing this alteration in epithelial phenotype, which
exhibits characteristics of a phenomenon known as in the diseased kidney (abstract; Rastaldi et al, J Am
Soc Nephrol 8:525A, 1997) [11]. The degree of transdif-“transdifferentiation.”
Transdifferentiation is a process whereby one cellular ferentiation correlated with the severity of tubular dam-
age and subsequent disease progression. Strutz et al iden-phenotype is lost, whereas another is gained by manipu-
lation of their environment [9]. It was widely assumed tified a specific fibroblast marker protein that they
termed FSP1 [12]. Mouse tubular epithelium transfectedthat interstitial fibroblasts were the main culprits for
extracellular matrix synthesis in tubulointerstitial fibro- with FSP1 began to show signs of transdifferentiation to
a more fibroblast-like phenotype associated with a loss ofsis. In recent studies performed in cultured cells and
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Fig. 2. Proposed sequence of events that lead
to tubulointerstitial fibrosis and eventually to
progressive renal disease.
cytokeratin expression and a gain of vimentin expression. the fact that we have observed sustained MAP kinase
activation parallel to the alterations in epithelial pheno-Okada et al demonstrated that mouse renal proximal
tubule epithelial cells exposed to the cytokines epidermal type induced by aPBMC supernatant in HPTs (unpub-
lished observations).growth factor (EGF) and transforming growth factor-b
(TGF-b) transdifferentiate to fibroblast-like cells with Studies by other laboratories have also examined the
consequences of cell–cell interactions in renal disease.increased expression of collagen, vimentin, FSP-1 and
a-smooth muscle actin [13]. FSP-1 antisense oligomers Dialyzed supernatants from lymphocytes from nephritic
animals were shown to stimulate both an increase inblocked this cytokine-induced epithelial transformation,
indicating that FSP1 expression is an important early fibroblast proliferation and collagen production. Super-
natants from control animal lymphocyte cultures con-event in the pathway toward transdifferentiation. MAP
kinase (MAPK) activation has been shown to mediate versely contained inhibitors of these two processes [15].
PBMC culture supernatants from patients with IgA ne-cellular differentiation in a number of cell systems. Ex-
tracellular signal-related kinase-1 and -2 (ERK1 and phropathy caused an increase in intercellular adhesion
molecule-1 expression on human mesangial cells in cul-ERK2) represent a subfamily of MAP kinases. Stable
expression of the upstream MAPK/ERK in renal epithe- ture [16]. An epithelial–lymphocyte interaction is not
unique to the kidney. Taylor et al have shown that cocul-lial cells also induces epithelial transdifferentiation to
fibroblast-like cells [14]. This is interesting in view of ture of T84 colonic epithelial cells with intraepithelial
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MR: Transforming growth factor b-1 regulates chemokine andlymphocytes induced decreases in the epithelial barrier
complement production by human proximal tubular epithelial cells.
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